bisoprolol has been researched along with Arrhythmia in 17 studies
Bisoprolol: A cardioselective beta-1 adrenergic blocker. It is effective in the management of HYPERTENSION and ANGINA PECTORIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Bisoprolol has anti-arrhythmic effects, but its direct effect on I(Na) in cardiac cells remains unclear." | 5.34 | Bisoprolol inhibits sodium current in ventricular myocytes of rats with diastolic heart failure. ( Deng, CY; Kuang, SJ; Tang, HF; Wu, SL; Zhang, WC, 2007) |
| "The authors describe two cases of takotsubo cardiomyopathy developing after an abrupt withdrawal of carvedilol and bisoprolol." | 3.79 | [Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome]. ( Arabadzisz, H; Jávor, K; Sármán, B; Tomcsányi, J; Wagner, V; Zsoldos, A, 2013) |
| "Carvedilol is one of the most effective beta blockers for preventing ventricular tachyarrhythmias in heart failure, but the mechanisms underlying its favorable antiarrhythmic benefits remain unclear." | 3.77 | Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release. ( Back, TG; Chen, H; Chen, J; Chen, SR; Chen, W; Cheng, H; Duff, HJ; Feldman, AM; Fill, M; Gillis, AM; Guo, A; Jiang, D; Jones, PP; Li, X; Smith, CD; Song, LS; Tian, X; Vembaiyan, K; Wang, A; Wang, R; Xiao, J; Xie, C; Yang, D; Zhang, J; Zhang, L; Zhong, X; Zhou, Q; Zhu, W, 2011) |
| "Baroreflex sensitivity was assessed in 287 patients with history of myocardial infarction and left ventricular ejection fraction < or =40% by phenylephrine test and was found to be depressed (4." | 3.72 | [Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction]. ( Bozhko, AA; Kanopskiĭ, SG; Staritskiĭ, AG, 2004) |
| "The heart failure is one of the pathologies with major social and economic impact in the western world." | 2.44 | [Chronic heart failure and sudden death: the message of CIBIS-III]. ( Dequarti, MC; Poggio, L; Vanoli, E, 2007) |
| "Strikingly, arrhythmia events were more frequently detected in BrS-hiPSC-CMs." | 1.72 | A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells. ( Akin, I; Albers, S; Cyganek, L; Diecke, S; Dinkel, H; Duru, F; El-Battrawy, I; Hohn, A; Huang, M; Janssen, JWG; Kleinsorge, M; Lan, H; Lang, S; Li, X; Li, Y; Liao, Z; Maywald, L; Müller, J; Qiao, L; Rose, L; Saguner, A; Schimanski, T; Swamy, N; Xi, Y; Xu, Q; Yang, Z; Zhang, F; Zhao, Z; Zhong, R; Zhou, X, 2022) |
| "Within the COPD GOLD II stage group, there appears to be no statistically significant difference in the number of exacerbations between the patients taking verapamil and digoxin (n = 24) and the patients taking BBs alone (n = 15), although, in patients taking BBs alone, there appears to be a trend towards a decrease in the exacerbations compared to the number of exacerbations in patients taking verapamil and digoxin (p = 0." | 1.51 | Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease. ( Bedak, O; Begic, E; Bradaric, H; Custovic, F; Durak-Nalbantic, A; Hodzic, E; Mujakovic, A; Prnjavorac, B; Zvizdic, F, 2019) |
| "Bisoprolol has anti-arrhythmic effects, but its direct effect on I(Na) in cardiac cells remains unclear." | 1.34 | Bisoprolol inhibits sodium current in ventricular myocytes of rats with diastolic heart failure. ( Deng, CY; Kuang, SJ; Tang, HF; Wu, SL; Zhang, WC, 2007) |
| "Bisoprolol have been confirmed to have strictly beta-blocking properties." | 1.27 | Electrophysiological effects of bisoprolol. ( Feruglio, GA; Gradnik, R; Proclemer, A; Savonitto, S, 1987) |
| "Bisoprolol was about 2 times more effective in suppressing isoprenaline-induced increases in LVdP/dtmax than those in heart rate." | 1.27 | Bisoprolol improves perfusion of ischaemic myocardium in anaesthetized pigs. ( den Boer, MO; Rensen, RJ; Sassen, LM; Saxena, PR; Verdouw, PD, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (17.65) | 18.7374 |
| 1990's | 1 (5.88) | 18.2507 |
| 2000's | 4 (23.53) | 29.6817 |
| 2010's | 8 (47.06) | 24.3611 |
| 2020's | 1 (5.88) | 2.80 |
| Authors | Studies |
|---|---|
| Zhong, R | 1 |
| Schimanski, T | 1 |
| Zhang, F | 1 |
| Lan, H | 1 |
| Hohn, A | 1 |
| Xu, Q | 1 |
| Huang, M | 1 |
| Liao, Z | 1 |
| Qiao, L | 1 |
| Yang, Z | 1 |
| Li, Y | 1 |
| Zhao, Z | 1 |
| Li, X | 2 |
| Rose, L | 1 |
| Albers, S | 1 |
| Maywald, L | 1 |
| Müller, J | 1 |
| Dinkel, H | 1 |
| Saguner, A | 1 |
| Janssen, JWG | 1 |
| Swamy, N | 1 |
| Xi, Y | 1 |
| Lang, S | 1 |
| Kleinsorge, M | 1 |
| Duru, F | 1 |
| Zhou, X | 1 |
| Diecke, S | 1 |
| Cyganek, L | 1 |
| Akin, I | 1 |
| El-Battrawy, I | 1 |
| Zvizdic, F | 1 |
| Begic, E | 1 |
| Mujakovic, A | 1 |
| Hodzic, E | 1 |
| Prnjavorac, B | 1 |
| Bedak, O | 1 |
| Custovic, F | 1 |
| Bradaric, H | 1 |
| Durak-Nalbantic, A | 1 |
| Higa, A | 1 |
| Hoshi, H | 1 |
| Yanagisawa, Y | 1 |
| Ito, E | 1 |
| Morisawa, G | 1 |
| Imai, JI | 1 |
| Watanabe, S | 1 |
| Takagi, M | 1 |
| Prajapati, C | 1 |
| Ojala, M | 1 |
| Aalto-Setälä, K | 1 |
| Swissa, M | 1 |
| Shimoni, S | 1 |
| Talotta, R | 1 |
| Atzeni, F | 1 |
| Batticciotto, A | 1 |
| Ventura, D | 1 |
| Sarzi-Puttini, P | 1 |
| Fazio, G | 1 |
| Sarulo, F | 1 |
| Licata, P | 1 |
| D'Angelo, L | 1 |
| Passantino, S | 1 |
| Visconti, C | 1 |
| Zarcone, P | 1 |
| Spanò, C | 1 |
| Novo, G | 1 |
| Novo, S | 1 |
| Zhou, Q | 1 |
| Xiao, J | 1 |
| Jiang, D | 1 |
| Wang, R | 1 |
| Vembaiyan, K | 1 |
| Wang, A | 1 |
| Smith, CD | 1 |
| Xie, C | 1 |
| Chen, W | 1 |
| Zhang, J | 1 |
| Tian, X | 1 |
| Jones, PP | 1 |
| Zhong, X | 1 |
| Guo, A | 1 |
| Chen, H | 1 |
| Zhang, L | 1 |
| Zhu, W | 1 |
| Yang, D | 1 |
| Chen, J | 1 |
| Gillis, AM | 1 |
| Duff, HJ | 1 |
| Cheng, H | 1 |
| Feldman, AM | 1 |
| Song, LS | 1 |
| Fill, M | 1 |
| Back, TG | 1 |
| Chen, SR | 1 |
| Tomcsányi, J | 1 |
| Jávor, K | 1 |
| Arabadzisz, H | 1 |
| Zsoldos, A | 1 |
| Wagner, V | 1 |
| Sármán, B | 1 |
| Kanopskiĭ, SG | 1 |
| Staritskiĭ, AG | 1 |
| Bozhko, AA | 1 |
| Tang, HF | 1 |
| Wu, SL | 1 |
| Deng, CY | 1 |
| Zhang, WC | 1 |
| Kuang, SJ | 1 |
| Dequarti, MC | 1 |
| Poggio, L | 1 |
| Vanoli, E | 1 |
| Biondi, B | 1 |
| Fazio, S | 1 |
| Carella, C | 1 |
| Sabatini, D | 1 |
| Amato, G | 1 |
| Cittadini, A | 1 |
| Bellastella, A | 1 |
| Lombardi, G | 1 |
| Saccà, L | 1 |
| Houle, MS | 1 |
| Altschuld, RA | 1 |
| Billman, GE | 1 |
| Ogawa, T | 1 |
| Hieda, N | 1 |
| Sugiyama, S | 1 |
| Ito, T | 1 |
| Satake, T | 1 |
| Ozawa, T | 1 |
| Proclemer, A | 1 |
| Gradnik, R | 1 |
| Savonitto, S | 1 |
| Feruglio, GA | 1 |
| Sassen, LM | 1 |
| den Boer, MO | 1 |
| Rensen, RJ | 1 |
| Saxena, PR | 1 |
| Verdouw, PD | 1 |
1 review available for bisoprolol and Arrhythmia
| Article | Year |
|---|---|
[Chronic heart failure and sudden death: the message of CIBIS-III].
Topics: Adrenergic beta-Antagonists; Aged; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents | 2007 |
16 other studies available for bisoprolol and Arrhythmia
| Article | Year |
|---|---|
A Preclinical Study on Brugada Syndrome with a CACNB2 Variant Using Human Cardiomyocytes from Induced Pluripotent Stem Cells.
Topics: Action Potentials; Arrhythmias, Cardiac; Bisoprolol; Brugada Syndrome; Calcium Channels, L-Type; Hum | 2022 |
Beta-blocker Use in Moderate and Severe Chronic Obstructive Pulmonary Disease.
Topics: Adrenergic beta-Antagonists; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bisoprolol; Case-Control | 2019 |
Evaluation system for arrhythmogenic potential of drugs using human-induced pluripotent stem cell-derived cardiomyocytes and gene expression analysis.
Topics: Amlodipine; Arrhythmias, Cardiac; Benzimidazoles; Biphenyl Compounds; Bisoprolol; Cardiotoxicity; Ce | 2017 |
Divergent effects of adrenaline in human induced pluripotent stem cell-derived cardiomyocytes obtained from hypertrophic cardiomyopathy.
Topics: Action Potentials; Arrhythmias, Cardiac; Bisoprolol; Cardiomyopathy, Hypertrophic; Epinephrine; Hear | 2018 |
Cardiac Tumor Lysis-Induced Ventricular Arrhythmia?
Topics: Adult; Anti-Arrhythmia Agents; Antineoplastic Combined Chemotherapy Protocols; Arrhythmias, Cardiac; | 2017 |
Possible relationship between certolizumab pegol and arrhythmias: report of two cases.
Topics: Aged; Antirheumatic Agents; Arrhythmias, Cardiac; Arthritis, Rheumatoid; Bisoprolol; Certolizumab Pe | 2016 |
Ivabradine versus bisoprolol.
Topics: Adrenergic beta-Antagonists; Aged; Angina Pectoris; Arrhythmias, Cardiac; Benzazepines; Bisoprolol; | 2010 |
Carvedilol and its new analogs suppress arrhythmogenic store overload-induced Ca2+ release.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Bisoprolol; Calcium; Calci | 2011 |
[Takotsubo cardiomyopathy: a novel beta-adrenergic blocker withdrawal syndrome].
Topics: Adrenergic beta-1 Receptor Antagonists; Adrenergic beta-Antagonists; Aged; Angiotensin-Converting En | 2013 |
[Correction of baroreflex sensitivity impairment and efficacy of prevention of sudden arrhythmic death in patients with postinfarction left ventricular dysfunction].
Topics: Adrenergic beta-Antagonists; Adult; Aged; Amiodarone; Angiotensin-Converting Enzyme Inhibitors; Anti | 2004 |
Bisoprolol inhibits sodium current in ventricular myocytes of rats with diastolic heart failure.
Topics: Animals; Anti-Arrhythmia Agents; Aorta, Abdominal; Aortic Coarctation; Arrhythmias, Cardiac; Bisopro | 2007 |
Control of adrenergic overactivity by beta-blockade improves the quality of life in patients receiving long term suppressive therapy with levothyroxine.
Topics: Adult; Arrhythmias, Cardiac; Bisoprolol; Echocardiography; Electrocardiography; Female; Heart Rate; | 1994 |
Enhanced in vivo and in vitro contractile responses to beta(2)-adrenergic receptor stimulation in dogs susceptible to lethal arrhythmias.
Topics: Adrenergic beta-2 Receptor Agonists; Adrenergic beta-Agonists; Adrenergic beta-Antagonists; Animals; | 2001 |
Cardioprotective and antiarrhythmic effects of beta-blockers, propranolol, bisoprolol, and nipradilol in a canine model of regional ischemia.
Topics: Acetylglucosaminidase; Adrenergic beta-Antagonists; Animals; Arrhythmias, Cardiac; Bisoprolol; Coron | 1989 |
Electrophysiological effects of bisoprolol.
Topics: Adrenergic beta-Antagonists; Aged; Arrhythmias, Cardiac; Atrioventricular Node; Bisoprolol; Bundle o | 1987 |
Bisoprolol improves perfusion of ischaemic myocardium in anaesthetized pigs.
Topics: Anesthesia; Animals; Arrhythmias, Cardiac; Bisoprolol; Coronary Circulation; Coronary Disease; Hemod | 1988 |